![COPD Article Thumbnail](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/COPD/Global/Articles/COPD-Article.png/jcr:content/COPD%20Article.webp)
Decoding Type 2 Inflammation in COPD: An Expert’s Perspective
Understanding type 2 inflammation is the key to managing symptoms and exacerbations of COPD.
Understanding type 2 inflammation is the key to managing symptoms and exacerbations of COPD.
Chronic Obstructive Pulmonary Disease (COPD) remains a significant health challenge worldwide, characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. Traditionally, COPD has been associated with neutrophil-driven inflammation, but recent insights suggest a more complex picture, involving Type 2 inflammation in a subset of patients. Dr. Surya Bhatt, a renowned COPD researcher and professor of medicine at the University of Alabama at Birmingham, provides valuable insights into this emerging area of COPD research.
Chronic Obstructive Pulmonary Disease (COPD) is a major health concern globally, with a significant impact on the quality of life and life expectancy of affected individuals. Surya Bhatt, a distinguished professor of medicine at the University of Alabama at Birmingham and a COPD researcher, provides valuable insights into the progression and management of this disease. This article will delve into key aspects of COPD exacerbations, drawing on the expertise of Dr. Bhatt to enhance our understanding.
Understanding type 2 inflammation may help shed light on why some patients continue to exacerbate. Watch this video to learn how.